Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Seek emergency medical treatment or contact the doctor in case of an overdose.
Deflazacort (moderate)
Dexamethasone (moderate)
Quetiapine (moderate)
Insulin (moderate)
Armodafinil (moderate)
Bexarotene (severe)
Dapagliflozin (moderate)
Budesonide (moderate)
Carbamazepine (moderate)
Acarbose (moderate)
Diltiazem (moderate)
Hydrocortisone (moderate)
Montelukast (moderate)
Triamcinolone (moderate)
Metformin (moderate)
This medicine is used for the treatment of growth failure due to inadequate secretion of the growth hormone. It is used to treat growth hormone deficiency in both children and adults. The lack of growth hormone in adults may or may not be coupled with multiple hormone deficiencies.
This medicine is used to treat extreme weight loss and muscle wasting in adults and children caused due to severe chronic illnesses such as AIDS and certain forms of cancer.
This medicine is used along with dietary adjustments and nutritional supplementation to treat short bowel syndrome in adults. Short bowel syndrome is a malabsorption disorder caused by a lack of functional small intestine, causing severe diarrhea, malnutrition, and weight loss.
This medicine is used to treat growth failure in girls associated with a congenital defect called Turner's syndrome.
This medicine is used to treat short stature in children, which is not attributed to the lack of growth hormone secretion.Growth retardation due to chronic renal failure
This medicine is used to treat growth deficiencies in children caused due to long-term kidney function impairment.
This medicine is used to treat growth deficiency in children, which is associated with a genetic disorder called Noonan Syndrome.
This medicine is used to treat short stature of children whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature.
Bone and joint pain
Puffy fingers
Swollen joints
Injection site bruising and red coloration
Burning, numbness, tingling in the arms and feet
Muscle cramps and stiffness
Severe headache (severe)
Visual disturbances (severe)
Nausea and Vomiting
Blood in urine and stools (severe)
Flu like symptoms (severe)
Confusion
Constipation
Difficult or painful urination
Dry mouth
Fast/irregular heart beat (severe)
Loss of appetite
Shivering (severe)
Yellowing of skin and eyes (severe)
White patches in the mouth or on the tongue
Mild to moderate depression (severe)
Hair loss or thinning of the hair (rare)
Diarrhea
Dizziness
This medicine is not recommended for use in patients with acute critical illness followed by open heart surgery, abdominal surgery, acute respiratory failure, or multiple accidental trauma due to the increased risk of mortality.
This medicine is not recommended for use in patients with Prader-Willi Syndrome who are severely obese or have a severe respiratory disease due to the increased risk of mortality.
This medicine is not recommended for use in patients with an active malignancy due to the increased risk of worsening of the patient’s condition. Any preexisting malignancy should be inactive and its treatment course should be completed for therapy with this medicine to begin.
This medicine is not recommended for use in patients with active proliferative or severe non-proliferative diabetic retinopathy due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for growth promotion in children with closed epiphyses.
This medicine is not recommended for use in patients with a known allergy to Humatrope Injection 15 IU 1 Vial , benzyl alcohol, or any other inactive ingredients present in the formulation.